findmyKOL
Clinical trialNCT05523947RecruitingPhase 1/PHASE2Interventional

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

SponsorYuhan CorporationEnrollment147HER2-Positive Solid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Southern Oncology Clinical Research Unit

    Adelaide, Australia

    Terminated
  • Austin Health

    Melbourne, Australia

    Recruiting
  • Breast Cancer Research Centre - Wa

    Perth, Australia

    Withdrawn
  • Blacktown Hospital

    Sydney, Australia

    Recruiting
South Korea
  • Cha Bundang Medical Center

    Seongnam-si, Gyeonggi-do, South Korea

    Recruiting
  • Ajou University Hospital

    Suwon, Gyeonggi-do, South Korea

    Recruiting
  • Catholic University of Korea St. Vincent'S Hospital

    Suwon, Gyeonggi-do, South Korea

    Recruiting
  • Gyeongsang National University Hospital

    Jinju, Gyeongsangnam-do, South Korea

    Recruiting
  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea

    Recruiting
  • Gachon Gil University Medical Center

    Incheon, South Korea

    Recruiting
  • Asan Medical Center

    Seoul, South Korea

    Recruiting
  • Korea University Anam Hospital

    Seoul, South Korea

    Recruiting
  • Samsung Medical Center

    Seoul, South Korea

    Recruiting
  • Seoul National University Hospital

    Seoul, South Korea

    Recruiting
  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

    Recruiting
  • the Catholic University of Korea, St. Mary'S Hospital

    Seoul, South Korea

    Recruiting
  • Ulsan University Hospital

    Ulsan, South Korea

    Recruiting
United States
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Recruiting
  • Vanderbilt Ingram Cancer Center

    Nashville, Tennessee, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Aug 2022
Primary completion
31 Mar 2028
Completion
30 Apr 2028
Last update posted
11 Jun 2026
Registered enrollment
147
Registry id
NCT05523947

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.